ALK's Clinical Research department conducts solid documentation studies of the efficacy of our products in co-operation with university hospitals and highly specialized experts. Studies are performed world-wide and focus on epidemiology, prevention, diagnosis and specific treatment of allergy.
Our clinical trials determine improved efficacy, quality of life, reduction in the use of symptomatic medication, cost-effectiveness, and alteration in the natural course of the disease. We also study the immunological mechanisms and long-term effects of allergy vaccination.
Clinical trial information
With reference to the decision from The European Federation of Pharmaceutical Industries and Associations (EFPIA) on the disclosure of information about clinical trials, ALK announces all clinical trials on www.clinicaltrials.gov